CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müllenheim, J.
Right arrow Articles by Schlack, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müllenheim, J.
Right arrow Articles by Schlack, W.
Canadian Journal of Anesthesia 48:784-789 (2001)
© Canadian Anesthesiologists' Society, 2001

Cardiothoracic Anesthesia, Respiration and Airway

Thiopentone does not block ischemic preconditioning in the isolated rat heart

[Le thiopental n'entrave pas le préconditionnement ischémique dans le coeur de rat isolé]

J. Müllenheim, MD*, A. Molojavyi, MD{dagger}, B. Preckel, MD DEAA*, V. Thämer, MD{dagger} and W. Schlack, MD DEAA*

* From the Departments of Anaesthesiology, and Physiology,
{dagger} Institut I Heinrich-Heine-Universität Düsseldorf Germany.

Address correspondence to: Dr. W. Schlack, Klinik für Anaesthesiologie Heinrich-Heine-Universität Postfach, 101007, 40001 Düsseldorf, Germany. Phone: +49-211-811-8669; Fax: +49-211-811-6253; E-mail: wolfgang{at}herzkreis.uni-duesseldorf.de

Purpose: Ischemic preconditioning protects the heart against subsequent prolonged ischemia by opening of adenosine triphosphate-sensitive potassium (KATP) channels. Thiopentone blocks KATP channels in isolated cells. Therefore, we investigated the effects of thiopentone on ischemic preconditioning.

Methods: Isolated rat hearts (n=56) were subjected to 30 min of global no-flow ischemia, followed by 60 min of reperfusion. Thirteen hearts underwent the protocol without intervention (control, CON) and in 11 hearts (preconditioning, PC), ischemic preconditioning was elicited by two five-minute periods of ischemia. In three additional groups, hearts received 1 (Thio 1, n=11), 10 (Thio 10, n=11) or 100 µg•mL–1 (Thio 100, n=10) thiopentone for five minutes before preconditioning. Left ventricular (LV) developed pressure and creatine kinase (CK) release were measured as variables of myocardial performance and cellular injury, respectively.

Results: Recovery of LV developed pressure was improved by ischemic preconditioning (after 60 min of reperfusion, mean ± SD: PC, 40 ± 19% of baseline) compared with the control group (5 ± 6%, P <0.01) and this improvement of myocardial function was not altered by administration of thiopentone (Thio 1, 37 ± 15%; Thio 10, 36 ± 16%; Thio 100, 38 ± 16%, P=0.87–0.99 vs PC). Total CK release over 60 min of reperfusion was reduced by preconditioning (PC, 202 ± 82 U•g–1 dry weight) compared with controls (CON, 383 ± 147 U•g–1, P <0.01) and this reduction was not affected by thiopentone (Thio 1, 213 ± 69 U•g–1; Thio 10, 211 ± 98 U•g–1; Thio 100, 258 ± 128 U•g–1, P=0.62–1.0 vs PC).

Conclusion: These results indicate that thiopentone does not block the cardioprotective effects of ischemic preconditioning in an isolated rat heart preparation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.